vTv Therapeutics Inc. (VTVT) stock
VTVTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3062% below fair value
$17.29−0.40 (-2.26%)
Close on Nov 17, 2026Market cap $68.37MP/E –Yield –
vTv Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
vTv Therapeutics's operating margin for the twelve months ending Jun 30, 2026 was -25.1%. For fiscal 2024 it was -2377.6%, against -1116.9% the year before. The highest annual figure on record is -159.4% in fiscal 2018.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -2377.6% | −1260.6 |
| FY2022 | Dec 31, 2022 | -1116.9% | −576.1 |
| FY2021 | Dec 31, 2021 | -540.9% | −356.1 |
| FY2020 | Dec 31, 2020 | -184.8% | +571.1 |
| FY2019 | Dec 31, 2019 | -755.9% | −596.4 |
| FY2018 | Dec 31, 2018 | -159.4% | +17257.1 |
| FY2017 | Dec 31, 2017 | -17416.5% | −8738.3 |
| FY2016 | Dec 31, 2016 | -8678.2% | −1329.1 |
| FY2015 | Dec 31, 2015 | -7349.1% | −5483.6 |
| FY2014 | Dec 31, 2014 | -1865.5% | +1805.9 |
| FY2013 | Dec 31, 2013 | -3671.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | 63.1% | +44807.6 |
| Q4 FY2024 | Dec 31, 2024 | -28776.5% | −28452.4 |
| Q1 FY2024 | Mar 31, 2024 | -562.7% | +122870.6 |
| Q4 FY2022 | Dec 31, 2022 | -70477.8% | −70424.3 |
| Q2 FY2022 | Jun 30, 2022 | -44744.4% | +7144.4 |
| Q1 FY2022 | Mar 31, 2022 | -324.1% | +109.6 |
| Q4 FY2021 | Dec 31, 2021 | -123433.3% | −123461.9 |
| Q3 FY2021 | Sep 30, 2021 | -53.4% | +40403.7 |
| Q2 FY2021 | Jun 30, 2021 | -51888.9% | +31186.1 |
| Q1 FY2021 | Mar 31, 2021 | -433.6% | +90823.5 |
| Q4 FY2020 | Dec 31, 2020 | 28.6% | +67841.1 |
| Q3 FY2020 | Sep 30, 2020 | -40457.1% | −40195.0 |
| Q1 FY2020 | Mar 31, 2020 | -83075.0% | −82609.5 |
| Q4 FY2019 | Dec 31, 2019 | -91257.1% | −91249.4 |
| Q3 FY2019 | Sep 30, 2019 | -67812.5% | −67768.6 |
| Q2 FY2019 | Jun 30, 2019 | -262.1% | +96.0 |
| Q1 FY2019 | Mar 31, 2019 | -465.5% | −22.9 |
| Q4 FY2018 | Dec 31, 2018 | -7.8% | +5473.8 |
| Q3 FY2018 | Sep 30, 2018 | -43.9% | +76896.1 |
| Q2 FY2018 | Jun 30, 2018 | -358.2% | +96680.3 |
| Q1 FY2018 | Mar 31, 2018 | -442.5% | +45404.1 |
| Q4 FY2017 | Dec 31, 2017 | -5481.5% | +29552.7 |
| Q3 FY2017 | Sep 30, 2017 | -76940.0% | −41340.0 |
| Q2 FY2017 | Jun 30, 2017 | -97038.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -45846.7% | – |
| Q4 FY2016 | Dec 31, 2016 | -35034.2% | – |
| Q3 FY2016 | Sep 30, 2016 | -35600.0% | – |
See a number that looks wrong?